The electricity and patience are out in the Chantilly neighborhood. Neighbors say the outage texts from Duke Energy is a ...

Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, announced today that the company will present four ...

In February 2010, aztreonam for inhalation solution (Cayston; Gilead) — an inhalable formulation of the monobactam antibiotic aztreonam and lysine — was approved by the US FDA to improve respiratory ...

The global smart inhalers market size was US$ 147.7 million in 2021. The global smart inhalers market size is forecast to reach US$ 1,116.5 million by 2030, growing at a compound annual growth rate ...

I'm Max Skor, a biotech analyst with Morgan Stanley, and I'm honored to have Will Lewis here, CEO of Insmed. Before we get started, though, I have to read some brief disclosures. For important ...

Shares of United Therapeutics UTHR surged 33% on Tuesday after it announced positive top-line results from the late-stage TETON-2 study evaluating the nebulized version of Tyvaso (treprostinil) in ...

In Villanueva, Misamis Oriental — where two coal-fired power plants dominate the skyline — residents live with health worries they've grown almost accustomed to. Many have accepted the trade-off, ...

F ew people have permeated the pop culture landscape like country star Willie Nelson. His winding climb up the record ...

A new Northwestern Medicine study is challenging long-held assumptions about chronic obstructive pulmonary disease (COPD), ...

In COPD, patient initiation and persistent use of guideline-concordant maintenance inhaled medications is subpar.

An EHR-embedded inpatient care pathway for COPD was tied to improved adherence to evidence-based practices, shorter hospital ...